Neuromodulation Devices Market 2027 By Type, Application, Biomaterial, End-User and Geography | The Insight Partners

Neuromodulation Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Internal, External); Application (SCS, DBS, VNS, SNS, GES, TENS, TMS); Biomaterial (Metallic, Polymeric, Ceramic); End-User (Hospitals, Clinics, Homecare) and Geography

Report Code: TIPRE00018069 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Neuromodulation is a novel technology used for stimulation of specific neurological sites and alteration of the nerve activity by electricity or chemical agents present in the body. Most of these devices uses electrical stimulation. Electrodes are attached to the spinal cord, brain or peripheral nerves for carrying out the procedure. Neuromodulation devices are used to enhance the quality of life or treat the people suffering from chronic conditions like tremor, fecal and urinary incontinence, chronic pain, dystonia Parkinson's disease, epilepsy, and other psychological disorders.

MARKET DYNAMICS

The key market drivers for Neuromodulation Devices Market Includes, increasing prevalence of neurological disorders across the globe along with rising geriatric population. Moreover, various government initiatives about spreading awareness about various neurological disorders is also expected to drive market growth during the forecast period. Additionally, various technological advancements in healthcare sector is also expected to boost market growth during the forecast period. Whereas, stringent regulatory approvals, lack of skilled professionals along with limited reimbursement policies are expected to restrain market growth during forecast period.

MARKET SCOPE

The "Neuromodulation Devices Market" is a specialized and in-depth study of the Medical Device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Neuromodulation Devices market with detailed market segmentation by type, application, biomaterial, end user. The Neuromodulation Devices Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Neuromodulation Devices Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Neuromodulation Devices Market is segmented on the basis of type, application, biomaterial and end user. On the basis of type the market is segmented as, external and internal. On the basis of application the market is segmented as, SCS, DBS, VNS, SNS, GES, TMS. On the basis of biomaterial the market is segmented as, metallic, polymeric, and ceramic. And on the basis of end user the market is segmented as, hospitals, clinics and home care.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Neuromodulation Devices Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Neuromodulation Devices Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Neuromodulation Devices Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Neuromodulation Devices Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Neuromodulation Devices Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Neuromodulation Devices Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Neuromodulation Devices market in the global market. Below mentioned is the list of few companies engaged in the Neuromodulation Devices Market.

The report also includes the profiles of key players in Neuromodulation Devices Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   St. Jude Medical, Inc.
  •   LivaNova PLC.
  •   Boston Scientific Corporation
  •   Aleva Neurotherapeutics SA
  •   Bioness Inc.
  •   EnteroMedics Inc.
  •   Nevro Corporation
  •   NeuroPace Inc.
  •   Synapse Biomedical, Inc.
  •   Neurosigma, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neuromodulation Devices Market - By Type
1.3.2 Neuromodulation Devices Market - By Application
1.3.3 Neuromodulation Devices Market - By Biomaterial
1.3.4 Neuromodulation Devices Market - By End-User
1.3.5 Neuromodulation Devices Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. NEUROMODULATION DEVICES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. NEUROMODULATION DEVICES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. NEUROMODULATION DEVICES MARKET - GLOBAL MARKET ANALYSIS
6.1. NEUROMODULATION DEVICES - GLOBAL MARKET OVERVIEW
6.2. NEUROMODULATION DEVICES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. NEUROMODULATION DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INTERNAL
7.3.1. Overview
7.3.2. Internal Market Forecast and Analysis
7.4. EXTERNAL
7.4.1. Overview
7.4.2. External Market Forecast and Analysis
8. NEUROMODULATION DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. SCS
8.3.1. Overview
8.3.2. SCS Market Forecast and Analysis
8.4. DBS
8.4.1. Overview
8.4.2. DBS Market Forecast and Analysis
8.5. VNS
8.5.1. Overview
8.5.2. VNS Market Forecast and Analysis
8.6. SNS
8.6.1. Overview
8.6.2. SNS Market Forecast and Analysis
8.7. GES
8.7.1. Overview
8.7.2. GES Market Forecast and Analysis
8.8. TENS
8.8.1. Overview
8.8.2. TENS Market Forecast and Analysis
8.9. TMS
8.9.1. Overview
8.9.2. TMS Market Forecast and Analysis
9. NEUROMODULATION DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - BIOMATERIAL
9.1. OVERVIEW
9.2. BIOMATERIAL MARKET FORECASTS AND ANALYSIS
9.3. METALLIC
9.3.1. Overview
9.3.2. Metallic Market Forecast and Analysis
9.4. POLYMERIC
9.4.1. Overview
9.4.2. Polymeric Market Forecast and Analysis
9.5. CERAMIC
9.5.1. Overview
9.5.2. Ceramic Market Forecast and Analysis
10. NEUROMODULATION DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. CLINICS
10.4.1. Overview
10.4.2. Clinics Market Forecast and Analysis
10.5. HOMECARE
10.5.1. Overview
10.5.2. Homecare Market Forecast and Analysis

11. NEUROMODULATION DEVICES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Neuromodulation Devices Market Overview
11.1.2 North America Neuromodulation Devices Market Forecasts and Analysis
11.1.3 North America Neuromodulation Devices Market Forecasts and Analysis - By Type
11.1.4 North America Neuromodulation Devices Market Forecasts and Analysis - By Application
11.1.5 North America Neuromodulation Devices Market Forecasts and Analysis - By Biomaterial
11.1.6 North America Neuromodulation Devices Market Forecasts and Analysis - By End-User
11.1.7 North America Neuromodulation Devices Market Forecasts and Analysis - By Countries
11.1.7.1 United States Neuromodulation Devices Market
11.1.7.1.1 United States Neuromodulation Devices Market by Type
11.1.7.1.2 United States Neuromodulation Devices Market by Application
11.1.7.1.3 United States Neuromodulation Devices Market by Biomaterial
11.1.7.1.4 United States Neuromodulation Devices Market by End-User
11.1.7.2 Canada Neuromodulation Devices Market
11.1.7.2.1 Canada Neuromodulation Devices Market by Type
11.1.7.2.2 Canada Neuromodulation Devices Market by Application
11.1.7.2.3 Canada Neuromodulation Devices Market by Biomaterial
11.1.7.2.4 Canada Neuromodulation Devices Market by End-User
11.1.7.3 Mexico Neuromodulation Devices Market
11.1.7.3.1 Mexico Neuromodulation Devices Market by Type
11.1.7.3.2 Mexico Neuromodulation Devices Market by Application
11.1.7.3.3 Mexico Neuromodulation Devices Market by Biomaterial
11.1.7.3.4 Mexico Neuromodulation Devices Market by End-User
11.2. EUROPE
11.2.1 Europe Neuromodulation Devices Market Overview
11.2.2 Europe Neuromodulation Devices Market Forecasts and Analysis
11.2.3 Europe Neuromodulation Devices Market Forecasts and Analysis - By Type
11.2.4 Europe Neuromodulation Devices Market Forecasts and Analysis - By Application
11.2.5 Europe Neuromodulation Devices Market Forecasts and Analysis - By Biomaterial
11.2.6 Europe Neuromodulation Devices Market Forecasts and Analysis - By End-User
11.2.7 Europe Neuromodulation Devices Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Neuromodulation Devices Market
11.2.7.1.1 Germany Neuromodulation Devices Market by Type
11.2.7.1.2 Germany Neuromodulation Devices Market by Application
11.2.7.1.3 Germany Neuromodulation Devices Market by Biomaterial
11.2.7.1.4 Germany Neuromodulation Devices Market by End-User
11.2.7.2 France Neuromodulation Devices Market
11.2.7.2.1 France Neuromodulation Devices Market by Type
11.2.7.2.2 France Neuromodulation Devices Market by Application
11.2.7.2.3 France Neuromodulation Devices Market by Biomaterial
11.2.7.2.4 France Neuromodulation Devices Market by End-User
11.2.7.3 Italy Neuromodulation Devices Market
11.2.7.3.1 Italy Neuromodulation Devices Market by Type
11.2.7.3.2 Italy Neuromodulation Devices Market by Application
11.2.7.3.3 Italy Neuromodulation Devices Market by Biomaterial
11.2.7.3.4 Italy Neuromodulation Devices Market by End-User
11.2.7.4 Spain Neuromodulation Devices Market
11.2.7.4.1 Spain Neuromodulation Devices Market by Type
11.2.7.4.2 Spain Neuromodulation Devices Market by Application
11.2.7.4.3 Spain Neuromodulation Devices Market by Biomaterial
11.2.7.4.4 Spain Neuromodulation Devices Market by End-User
11.2.7.5 United Kingdom Neuromodulation Devices Market
11.2.7.5.1 United Kingdom Neuromodulation Devices Market by Type
11.2.7.5.2 United Kingdom Neuromodulation Devices Market by Application
11.2.7.5.3 United Kingdom Neuromodulation Devices Market by Biomaterial
11.2.7.5.4 United Kingdom Neuromodulation Devices Market by End-User
11.2.7.6 Rest of Europe Neuromodulation Devices Market
11.2.7.6.1 Rest of Europe Neuromodulation Devices Market by Type
11.2.7.6.2 Rest of Europe Neuromodulation Devices Market by Application
11.2.7.6.3 Rest of Europe Neuromodulation Devices Market by Biomaterial
11.2.7.6.4 Rest of Europe Neuromodulation Devices Market by End-User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Neuromodulation Devices Market Overview
11.3.2 Asia-Pacific Neuromodulation Devices Market Forecasts and Analysis
11.3.3 Asia-Pacific Neuromodulation Devices Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Neuromodulation Devices Market Forecasts and Analysis - By Application
11.3.5 Asia-Pacific Neuromodulation Devices Market Forecasts and Analysis - By Biomaterial
11.3.6 Asia-Pacific Neuromodulation Devices Market Forecasts and Analysis - By End-User
11.3.7 Asia-Pacific Neuromodulation Devices Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Neuromodulation Devices Market
11.3.7.1.1 Australia Neuromodulation Devices Market by Type
11.3.7.1.2 Australia Neuromodulation Devices Market by Application
11.3.7.1.3 Australia Neuromodulation Devices Market by Biomaterial
11.3.7.1.4 Australia Neuromodulation Devices Market by End-User
11.3.7.2 China Neuromodulation Devices Market
11.3.7.2.1 China Neuromodulation Devices Market by Type
11.3.7.2.2 China Neuromodulation Devices Market by Application
11.3.7.2.3 China Neuromodulation Devices Market by Biomaterial
11.3.7.2.4 China Neuromodulation Devices Market by End-User
11.3.7.3 India Neuromodulation Devices Market
11.3.7.3.1 India Neuromodulation Devices Market by Type
11.3.7.3.2 India Neuromodulation Devices Market by Application
11.3.7.3.3 India Neuromodulation Devices Market by Biomaterial
11.3.7.3.4 India Neuromodulation Devices Market by End-User
11.3.7.4 Japan Neuromodulation Devices Market
11.3.7.4.1 Japan Neuromodulation Devices Market by Type
11.3.7.4.2 Japan Neuromodulation Devices Market by Application
11.3.7.4.3 Japan Neuromodulation Devices Market by Biomaterial
11.3.7.4.4 Japan Neuromodulation Devices Market by End-User
11.3.7.5 South Korea Neuromodulation Devices Market
11.3.7.5.1 South Korea Neuromodulation Devices Market by Type
11.3.7.5.2 South Korea Neuromodulation Devices Market by Application
11.3.7.5.3 South Korea Neuromodulation Devices Market by Biomaterial
11.3.7.5.4 South Korea Neuromodulation Devices Market by End-User
11.3.7.6 Rest of Asia-Pacific Neuromodulation Devices Market
11.3.7.6.1 Rest of Asia-Pacific Neuromodulation Devices Market by Type
11.3.7.6.2 Rest of Asia-Pacific Neuromodulation Devices Market by Application
11.3.7.6.3 Rest of Asia-Pacific Neuromodulation Devices Market by Biomaterial
11.3.7.6.4 Rest of Asia-Pacific Neuromodulation Devices Market by End-User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Neuromodulation Devices Market Overview
11.4.2 Middle East and Africa Neuromodulation Devices Market Forecasts and Analysis
11.4.3 Middle East and Africa Neuromodulation Devices Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Neuromodulation Devices Market Forecasts and Analysis - By Application
11.4.5 Middle East and Africa Neuromodulation Devices Market Forecasts and Analysis - By Biomaterial
11.4.6 Middle East and Africa Neuromodulation Devices Market Forecasts and Analysis - By End-User
11.4.7 Middle East and Africa Neuromodulation Devices Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Neuromodulation Devices Market
11.4.7.1.1 South Africa Neuromodulation Devices Market by Type
11.4.7.1.2 South Africa Neuromodulation Devices Market by Application
11.4.7.1.3 South Africa Neuromodulation Devices Market by Biomaterial
11.4.7.1.4 South Africa Neuromodulation Devices Market by End-User
11.4.7.2 Saudi Arabia Neuromodulation Devices Market
11.4.7.2.1 Saudi Arabia Neuromodulation Devices Market by Type
11.4.7.2.2 Saudi Arabia Neuromodulation Devices Market by Application
11.4.7.2.3 Saudi Arabia Neuromodulation Devices Market by Biomaterial
11.4.7.2.4 Saudi Arabia Neuromodulation Devices Market by End-User
11.4.7.3 U.A.E Neuromodulation Devices Market
11.4.7.3.1 U.A.E Neuromodulation Devices Market by Type
11.4.7.3.2 U.A.E Neuromodulation Devices Market by Application
11.4.7.3.3 U.A.E Neuromodulation Devices Market by Biomaterial
11.4.7.3.4 U.A.E Neuromodulation Devices Market by End-User
11.4.7.4 Rest of Middle East and Africa Neuromodulation Devices Market
11.4.7.4.1 Rest of Middle East and Africa Neuromodulation Devices Market by Type
11.4.7.4.2 Rest of Middle East and Africa Neuromodulation Devices Market by Application
11.4.7.4.3 Rest of Middle East and Africa Neuromodulation Devices Market by Biomaterial
11.4.7.4.4 Rest of Middle East and Africa Neuromodulation Devices Market by End-User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Neuromodulation Devices Market Overview
11.5.2 South and Central America Neuromodulation Devices Market Forecasts and Analysis
11.5.3 South and Central America Neuromodulation Devices Market Forecasts and Analysis - By Type
11.5.4 South and Central America Neuromodulation Devices Market Forecasts and Analysis - By Application
11.5.5 South and Central America Neuromodulation Devices Market Forecasts and Analysis - By Biomaterial
11.5.6 South and Central America Neuromodulation Devices Market Forecasts and Analysis - By End-User
11.5.7 South and Central America Neuromodulation Devices Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Neuromodulation Devices Market
11.5.7.1.1 Brazil Neuromodulation Devices Market by Type
11.5.7.1.2 Brazil Neuromodulation Devices Market by Application
11.5.7.1.3 Brazil Neuromodulation Devices Market by Biomaterial
11.5.7.1.4 Brazil Neuromodulation Devices Market by End-User
11.5.7.2 Argentina Neuromodulation Devices Market
11.5.7.2.1 Argentina Neuromodulation Devices Market by Type
11.5.7.2.2 Argentina Neuromodulation Devices Market by Application
11.5.7.2.3 Argentina Neuromodulation Devices Market by Biomaterial
11.5.7.2.4 Argentina Neuromodulation Devices Market by End-User
11.5.7.3 Rest of South and Central America Neuromodulation Devices Market
11.5.7.3.1 Rest of South and Central America Neuromodulation Devices Market by Type
11.5.7.3.2 Rest of South and Central America Neuromodulation Devices Market by Application
11.5.7.3.3 Rest of South and Central America Neuromodulation Devices Market by Biomaterial
11.5.7.3.4 Rest of South and Central America Neuromodulation Devices Market by End-User

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. NEUROMODULATION DEVICES MARKET, KEY COMPANY PROFILES
13.1. ST. JUDE MEDICAL, INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. LIVANOVA PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BOSTON SCIENTIFIC CORPORATION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ALEVA NEUROTHERAPEUTICS SA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIONESS INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ENTEROMEDICS INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NEVRO CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NEUROPACE INC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SYNAPSE BIOMEDICAL, INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. NEUROSIGMA, INC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. St. Jude Medical, Inc
2. LivaNova PLC
3. Boston Scientific Corporation
4. Aleva Neurotherapeutics SA
5. Bioness Inc
6. EnteroMedics Inc
7. Nevro Corporation
8. NeuroPace Inc
9. Synapse Biomedical, Inc
10. Neurosigma, Inc
TIPRE00018069
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking